What is CJC 1295? How Does it Work?
CJC 1295 is a synthetic peptide. It belongs to the group of Growth Hormone-Releasing Hormones (GHRH). The GHRHs are those compounds that influence the pathways related to the pituitary gland. CJC1295, being a GHRH, also influences pituitary gland pathways and may modulate growth hormone secretion in research models. The growth hormone secretion may modulate multiple pathways in experimental models during laboratory trials. One of its impacts is affecting the patterns linked with IGF-1 secretion in research models. IGF-1, in combination with growth hormones, may modulate indicators associated with muscle hypertrophy, skeletal integrity, and endurance in research subjects during laboratory studies.Comparison of CJC 1295 DAC and CJC 1295 With No DAC
Here is a detailed comparison between CJC 1295 with DAC and without DAC. Let’s have a look at it!What is CJC1295 with DAC?
DAC stands for Drug Affinity Complex, a type of protein. The basic science behind this addition is to enhance its half-life and activities in research models. After adding DAC to CJC1295, the half-life of the compound extends to 6 to 8 days from just 30 minutes. The influence on growth hormones is also sustained and extended.
Features of CJC1295 with DAC
- Half-Life: After adding DAC to CJC1295, its half-life extends. According to animal model studies, the half-life of CJC 1295 was increased by approximately 6 to 8 days with DAC addition.
- Dosing Frequency: The dosing frequency also decreases after the addition of DAC. With DAC, the dose is administered to research models either biweekly or weekly.
- GH Releasing Patterns: The patterns influenced by CJC1295 with DAC are more sustainable and long-term. It modulates continuous growth hormone secretion in research subjects.
What is CJC 1295 without DAC?
CJC 1295 without DAC is a standard CJC synthetic compound. It has a shorter half-life, approximately 30 to 40 minutes, in research models. After that, it disappears gradually. The short half-life is due to the absence of DAC attachment at the end. Its effects on research subjects are brief and temporary.
Features of CJC 1295 without DAC
- Short Half-Life: The half-life of CJC 1295 without a DAC is short, typically lasting a few minutes. For instance, an animal model study found that the half-life of CJC 1295 with no DAC is 30 to 40 minutes in research models. After this duration, the effects of CJC gradually disappear.
- Dose Frequency: The dosing frequency of CJC 1295 without DAC is typically high or frequent. This frequency of dose helps maintain balanced growth hormone levels in research subjects.
- GH Releasing Patterns: The patterns of releasing growth hormone levels are also temporary in research subjects during clinical trials, as it has a shorter half-life.
Potential Benefits of CJC 1295
The potential benefits of CJC 1295 in research models are as follows:Influencing Growth Hormone Patterns
The first and foremost demonstration of CJC 1295 in research subjects is its influence on the patterns associated with growth hormones. According to laboratory trials, CJC 1295 may act as GHRH and influence the pituitary gland in laboratory models. The pituitary gland, in turn, modulates the secretion of growth hormones in research subjects.Modulates Muscle Growth
Another demonstration of CJC 1295 in research models is its influence on muscle hypertrophy. The CJC-induced growth hormones in research subjects influence multiple pathways. For instance, these growth hormones may help prevent muscle wasting and facilitate protein synthesis. The prevention of muscle wasting and facilitation of protein modulates muscle growth in research models during clinical trials.Affects Skeletal Integrity
One of the influences of CJC 1295 on skeletal integrity has been observed in research models during laboratory trials. According to laboratory studies, CJC 1295 may enhance the activities of osteoblast cells in research subjects. Osteoblast cells may affect skeletal integrity in research models during laboratory trials.Associated Side Effects of CJC 1295
The commonly observed side effects of CJC 1295 in subjects are as follows:- Injection site reaction
- Pain
- Redness
- Swelling
- Flushing
- Dizziness
- Hyperactivity






